ConductScience.org, home

Paper36061376

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance.

Sundararaman SA and 1 other. Front Pediatr, 2022. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance. Papers, record 36061376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36061376

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance.
PubMed
Journal
Front Pediatr
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2022-09-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sundararaman SASesh A
2Odom John ARAudrey R

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111425176The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa.Am J Trop Med Hyg2001https://conductscience.org/library/papers/11425176PubMed
29840604Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.Am J Trop Med Hyg1998https://conductscience.org/library/papers/9840604PubMed
321765069Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.Clin Infect Dis2011https://conductscience.org/library/papers/21765069PubMed
433891721Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33891721PubMed
528785011Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa.Sci Rep2017https://conductscience.org/library/papers/28785011PubMed
630922818Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.Lancet Infect Dis2019https://conductscience.org/library/papers/30922818PubMed
714096460CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE.Br Med J1964https://conductscience.org/library/papers/14096460PubMed
824028889Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria.Trends Parasitol2013https://conductscience.org/library/papers/24028889PubMed
911807721Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.J Infect Dis2002https://conductscience.org/library/papers/11807721PubMed
1031345710Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.Lancet Infect Dis2019https://conductscience.org/library/papers/31345710PubMed
11400205Falciparum malaria and pregnancy.Trans R Soc Trop Med Hyg1979https://conductscience.org/library/papers/400205PubMed
1222850522Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22850522PubMed
1330910321Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.Lancet2019https://conductscience.org/library/papers/30910321PubMed
1433020152Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/33020152PubMed
1526325263Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.Trop Med Int Health2015https://conductscience.org/library/papers/26325263PubMed
1626962728Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.N Engl J Med2016https://conductscience.org/library/papers/26962728PubMed
1728968782Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.J Infect Dis2017https://conductscience.org/library/papers/28968782PubMed
1827622558
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
PLoS Med2016https://conductscience.org/library/papers/27622558PubMed
1915482398Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.Trop Med Int Health2004https://conductscience.org/library/papers/15482398PubMed
2032772921
Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
BMC Med2020https://conductscience.org/library/papers/32772921PubMed

See all 48 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42958321Placental malaria and preeclampsia: shared pathways and translational perspectives in endemic regions.Malar J2026https://conductscience.org/library/papers/42958321PubMed
42383988Indole-based hybrids target both asexual parasites and gametocytes of Plasmodium falciparum and synergize with lumefantrine.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42383988PubMed
42198630Prevalence of pfdhfr-pfdhps Sextuple and Gametocyte-Associated Quintuple Sulfadoxine-Pyrimethamine Resistance Mutations in Plasmodium falciparum Isolates from Pregnant Women in Mozambique.Pathogens2026https://conductscience.org/library/papers/42198630PubMed
42188751Modelling the Cost-Effectiveness of a Placental Malaria Vaccine in Sub-Saharan Africa.Vaccines (Basel)2026https://conductscience.org/library/papers/42188751PubMed
41824506Improving malaria chemoprevention coverage in pregnancy: Surveying stakeholder preferences for new product profiles and community-delivery approaches across five African countries.PLOS Glob Public Health2026https://conductscience.org/library/papers/41824506PubMed
41639729Malaria: a review on its current epidemiological status and management strategies.Malar J2026https://conductscience.org/library/papers/41639729PubMed
41469677Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda.Malar J2025https://conductscience.org/library/papers/41469677PubMed
41219797Polymorphism of the dihydropteroate synthase resistance gene of Plasmodium falciparum in three hospitals in Mbouda, Western Cameroon.Trop Dis Travel Med Vaccines2025https://conductscience.org/library/papers/41219797PubMed
41191181Advancing malaria treatment with magnetic and mesoporous silica nanoparticles loaded with sulfadoxine-pyrimethamine: a review.Discov Nano2025https://conductscience.org/library/papers/41191181PubMed
41001541Maternal and household risk factors for malaria in pregnancy and low birthweight: a prospective cohort study from Uganda.Res Sq2025https://conductscience.org/library/papers/41001541PubMed
39806485Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study.Malar J2025https://conductscience.org/library/papers/39806485PubMed
37754682Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso.Infect Immun2023https://conductscience.org/library/papers/37754682PubMed
37090061Perceptions of sulphadoxine-pyrimethamine use among pregnant women in sub-Saharan Africa: a scoping review.Malariaworld J2023https://conductscience.org/library/papers/37090061PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DHFR1719PubTator's text mininghttps://conductscience.org/library/genes/1719NCBI Gene
DHPS1725PubTator's text mininghttps://conductscience.org/library/genes/1725NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36061376

GET https://conductscience.org/api/papers/v1/36061376/references?page=2